CVS Health Corporation (CVS) EBITDA margin US GAAP (year values) |
|||||||||
2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
EBITDA margin, % | ? | 6.42% | 6.91% | 6.74% | 6.21% | 5.17% | 4.59% | ||
Changes by years, y/y, % | 0pp | +0pp | 0pp | -1pp | -1pp | -4.8% |
CVS Health Corporation. EBITDA margin, %
CVS Health Corporation. EBITDA margin, changes, pp
CVS Health Corporation (CVS) EBITDA margin US GAAP (quarter values) |
||||||||
2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | LTM ? | |||
EBITDA margin, % | ? | 5.32% | 5.19% | 4.89% | 3.43% | 4.80% | 4.59% | |
Changes by years, y/y, % | -2pp | -1pp | +0pp | -2pp | -1pp | |||
Changes by quarters, q/q, % | 0pp | 0pp | 0pp | -1pp | +1pp |